India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...
Jipmer enrolls first infant in NeoSep1 international clinical trial in fight against neonatal sepsis
Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.
Flosonics Medical received the Paul and Debra Walker Award, part of the Sepsis Research and Innovation Challenge at the Unite for Sepsis Symposium presented by Sepsis Alliance in Washington, D.C. on ...
Will AI replace healthcare jobs? Not exactly. Learn which roles face the greatest disruption, which remain resilient, and how ...
The Integrated Assessment Tool assesses aged care needs to determine eligibility for government-supported aged care services.
A landmark Harvard University study tracking 147,000 adults over 30 years has found that just 90 to 119 minutes of weekly ...
Several Twin Cities beaches are temporarily closed due to Escherichia coli, also known as E. coli, according to city and ...
India Today on MSN
Indian newborns join global race to beat deadly drug-resistant sepsis
India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...
The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...
7don MSNOpinion
5 things to keep in mind about AI hype
The first step to understanding AI’s real potential is turning down the volume on the people who are selling it most loudly.
The federal government has quietly launched a rapid review into a controversial algorithm after older Australians sound the ...
The rapid rollout of artificial intelligence (AI) in nursing requires active oversight by nurses to safeguard patient safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results